Identification of degradation products of Ibuprofen arising from oxidative and thermal treatments

被引:117
作者
Caviglioli, G
Valeria, P
Brunella, P
Sergio, C
Attilia, A
Gaetano, B
机构
[1] Univ Studi Genova, Dipartimento Chim & Tecnol Farmaceut & Alimentari, I-16147 Genoa, Italy
[2] Pharmatec Int SRL, I-20098 S Giuliano Milanese, Italy
关键词
Ibuprofen; degradation products; oxidation; HPLC; GC-MS; methyl derivatives;
D O I
10.1016/S0731-7085(02)00400-4
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Ibuprofen is a widely utilised analgesic anti-inflammatory drug. It is sensitive to oxidation and photodegradation. In this work, the oxidative and thermal degradations were investigated. The treatments adopted allowed the detection of 13 degradation products, seven of which have never been reported: hydratropic acid, 4-ethylbenzaldehyde, 4-(1-carboxyethyl)benzoic acid, 1-(4-isobutylphenyl)-1-ethanol, 2-[4-(1-hydroxy-2-methylpropyl)phenyl]propanoic acid, 1-isobutyl-4-vinylbenzene, 4-isobutylphenol. For 1-(4-isobutylphenyl)-1-ethanol, the in vitro toxic effects have already been described in the literature. To detect all degradation products, two RP-HPLC methods and a GC-MS procedure were developed or modified from the official monographs. The identification was conducted by evaluating chromatographic and spectral data and the structural attributions were confirmed by simple and univocal synthesis. Moreover, the actual presence of these molecules in marketed medicinal products was investigated. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:499 / 509
页数:11
相关论文
共 16 条
[1]   DETERMINATION OF 2-(4-ISOBUTYLPHENYL)PROPIONIC ACID IN BULK DRUG AND COMPRESSED TABLETS BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
ASMUS, PA .
JOURNAL OF CHROMATOGRAPHY, 1985, 331 (01) :169-176
[2]   PHOTOLYTIC DEGRADATION OF IBUPROFEN - TOXICITY OF THE ISOLATED PHOTOPRODUCTS ON FIBROBLASTS AND ERYTHROCYTES [J].
CASTELL, JV ;
GOMEZ, MJ ;
MIRANDA, MA ;
MORERA, IM .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1987, 46 (06) :991-996
[3]  
DONDOI A, 1986, IL FARMACO, V7, P237
[4]  
GOODMANS, 1990, PHARM BASIS THERAPEU, P665
[5]  
HEIKKINEN L, 1983, ACTA PHARM FENN, V92, P275
[6]  
KEPP DR, 1997, PHARMACEUT RES, V5, P676
[7]  
LEE J, 1995, PHARMACEUT RES, V9, pS170
[8]  
Reynold JEF, 1996, MARTINDALE EXTRA PHA, P50
[9]  
SUN YL, 1993, J CHROMATOGR A, V657, P1
[10]  
VARGAS F, 1991, PHARMAZIE, V46, P767